Israel’s Laniado hospital used groundbreaking stem cell treatment from Israel’s BioGenCell to save amputating the legs of five diabetic patients with poor circulation. Stem cells from the patients’ blood injected into their leg muscles grew new blood vessels to bypass blockages.
50 doctors at Haifa’s Rambam Medical Center have performed “the impossible”. They conducted three highly complex operations to save a 2kg premature baby that was born with a rare “teratoma” – a 1kg tumor attached to her brain, jaw, neck, chest, airways and blood vessels.
Israel’s STS Medical has received regulatory clearance from the US FDA for its composite sinus stent. Following nasal surgery (e.g. on sinusitis and allergic rhinitis sufferers where other treatments have not worked) the stent keeps the nasal airways open to allow the sinus tissue to heal.
Israel’s Check-cap has just received the CE Mark for its C-Scan ingestible capsule for preparation-free, colorectal cancer screening. The capsule uses low-dose X-rays to obtain 3D images of the colon whilst allowing patients to go about their normal daily routines.
Israeli startup Motus GI has developed the FDA-approved Pure-Vu system, that allowing doctors to clean poorly prepped colons during a colonoscopy. It would make preparing for a colonoscopy much easier. Motus is preparing a NASDAQ launch to raise up to $28.8 million.
Israel’s Accurate Medical has developed a range of microcatheters for cutting off the blood supply (embolization) to tumors and vascular aneurysms. French medical imaging company Guerbet has just acquired Accurate for up to 57 million Euros. Accurate will continue to operate from Israel.
I reported previously (Oct 2012) that Israeli bio-tech Metallo Therapy was using gold nanoparticles to improve radiotherapy treatment for cancer. Unfortunately, Metallo folded in 2016, but now a team of Israeli researchers are headed down the same precious “yellow-brick” road.
The Rapid Cancer Diagnostic Unit at Sheba Medical Center uses new diagnostic oncology technology developed by Dr. Damien Urban. It cuts patient waiting time from previously 3 months to just two weeks. Its goal is to help overcome the devastating delays in the diagnosis and treatment of cancer.
Israeli health fund Maccabi has launched K Health - an app to give its customers medical advice that many seek currently by using search engines such as Google. The information is sourced from thousands of similar cases in Maccabi’s records database. Currently in Hebrew and Israel only.
Israeli companies HeartBeat Technologies and Brainsway have been selected for a joint Israel-Canada partnership program. They will test their innovative aging and brain health solutions at two Canadian seniors care organizations.